Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Non-cash Items: 2023-2025

Historic Non-cash Items for Orchestra BioMed Holdings (OBIO) over the last 3 years, with Sep 2025 value amounting to $8.6 million.

  • Orchestra BioMed Holdings' Non-cash Items rose 160.06% to $8.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.6 million, marking a year-over-year increase of 160.06%. This contributed to the annual value of $3.5 million for FY2024, which is 57.39% down from last year.
  • Per Orchestra BioMed Holdings' latest filing, its Non-cash Items stood at $8.6 million for Q3 2025, which was up 111.18% from $4.1 million recorded in Q2 2025.
  • In the past 5 years, Orchestra BioMed Holdings' Non-cash Items ranged from a high of $11.6 million in Q2 2024 and a low of $2.4 million during Q3 2023.
  • For the 3-year period, Orchestra BioMed Holdings' Non-cash Items averaged around $6.7 million, with its median value being $7.4 million (2023).
  • The largest annual percentage gain for Orchestra BioMed Holdings' Non-cash Items in the last 5 years was 160.06% (2025), contrasted with its biggest fall of 64.89% (2025).
  • Quarterly analysis of 3 years shows Orchestra BioMed Holdings' Non-cash Items stood at $8.2 million in 2023, then grew by 13.61% to $9.3 million in 2024, then skyrocketed by 160.06% to $8.6 million in 2025.
  • Its last three reported values are $8.6 million in Q3 2025, $4.1 million for Q2 2025, and $3.7 million during Q1 2025.